相关实验视频

Updated: Feb 14, 2026

Isolation, Characterization and Functional Examination of the Gingival Immune Cell Network

Isolation, Characterization and Functional Examination of the Gingival Immune Cell Network

Published on: February 16, 2016

慢性阻塞性肺病通过训练免疫,细胞死亡网络和免疫检查点调节障碍将肺重编为免疫器官

Fatma Saaoud¹, Keman Xu¹, Yifan Lu¹

¹Lemole Center for Integrated Lymphatics and Vascular Research, Department of Cardiovascular Sciences, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, United States.

Frontiers in medicine

|February 13, 2026

概括

慢性阻塞性肺病 (COPD) 通过改变细胞身份和激活细胞死亡途径,将肺部转化为类似免疫器官. 这些发现揭示了COPD免疫调节的新治疗点.

科学领域:

肺部医学肺部医学
免疫学免疫学免疫学
文字转录学 (Transcriptomics) 是一个学科.

背景情况:

慢性阻塞性肺病 (COPD) 是一种复杂的炎症性肺病,具有渐进的结构损伤.
慢性肺炎对肺架构,免疫信号和细胞身份的系统性影响尚未完全理解.

研究的目的:

为了研究人类COPD肺部的多维转录基因变化.
评估COPD免疫信号传递,细胞死亡,纤维化,细胞身份和免疫检查点的变化.

主要方法:

对人类COPD肺部数据集的综合性,多维的转录组分析.
评估针对训练有素免疫路径的遗传和细胞因子干扰.

主要成果:

慢性肺炎上调免疫,分泌和训练免疫基因,SET7缺乏或IL-37过度表达减弱了这些影响.
组织损伤通过多种调节细胞死亡途径的上调和增强纤维化而得到促进.
在10/14种肺细胞类型中,细胞身份被破坏,显示出病理性转基因分化.
在膜巨细胞中观察到免疫检查点失调,调节性T细胞功能受损.

结论:

慢性肺炎通过结构性细胞转差和改变免疫信号,将肺部重新编程为类似免疫器官.
该研究确定了COPD免疫调节干预措施的潜在治疗点.

关键词:

慢性慢性肺炎是一种慢性慢性肺炎,COPD是一种慢性肺炎.皮质转化为介质细胞的过渡 (EMT)免疫器官免疫器官它们有秘密的细胞体.训练有素的免疫力

更多相关视频

Characterization of Immune Cells and Proinflammatory Mediators in the Pulmonary Environment

Characterization of Immune Cells and Proinflammatory Mediators in the Pulmonary Environment

Published on: June 24, 2020

Flow Cytometric Analysis for Identification of the Innate and Adaptive Immune Cells of Murine Lung

Flow Cytometric Analysis for Identification of the Innate and Adaptive Immune Cells of Murine Lung

Published on: November 16, 2021

相关概念视频

What is the Immune System?

What is the Immune System?

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

Humoral Immune Responses

Humoral Immune Responses

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

Chronic Obstructive Pulmonary Disease-V: Management

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation